Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro

Neuroscience. 2014 Jan 3;256:456-66. doi: 10.1016/j.neuroscience.2013.10.029. Epub 2013 Oct 21.

Abstract

Nogo-A is a transmembrane protein originally discovered in myelin, produced by postnatal CNS oligodendrocytes. Nogo-A induces growth cone collapse and inhibition of axonal growth in the injured adult CNS. In the intact CNS, Nogo-A functions as a negative regulator of growth and plasticity. Nogo-A is also expressed by certain neurons. Neuronal Nogo-A depresses long-term potentiation in the hippocampus and modulates neurite adhesion and fasciculation during development in mice. Here we show that Nogo-A is present in neurons derived from human midbrain (Lund human mesencephalic (LUHMES) cell line), as well as in embryonic and postnatal mouse midbrain (dopaminergic) neurons. In LUHMES cells, Nogo-A was upregulated threefold upon differentiation and neurite extension. Nogo-A was localized intracellularly in differentiated LUHMES cells. Cultured midbrain (dopaminergic) neurons from Nogo-A knock-out mice exhibited decreased numbers of neurites and branches when compared with neurons from wild-type (WT) mice. However, this phenotype was not observed when the cultures from WT mice were treated with an antibody neutralizing plasma membrane Nogo-A. In vivo, neither the regeneration of nigrostriatal tyrosine hydroxylase fibers, nor the survival of nigral dopaminergic neurons after partial 6-hydroxydopamine lesions was affected by Nogo-A deletion. These results indicate that during maturation of cultured midbrain (dopaminergic) neurons, intracellular Nogo-A supports neurite growth initiation and branch formation.

Keywords: 3,3′-diaminobenzidine; 4′,6-diamidino-2-phenylindole; 6-OHDA; 6-hydroxydopamine; ANOVA; DAB; DAPI; DMEM; Dulbecco’s Modified Eagle Medium; EDTA; FCS; GDNF; Glial cell line-derived neurotrophic factor; HBSS; HRP; Hanks Balanced Salt Solution; KO; LUHMES cells; Lund human nesencephalic cells; Nogo-A; PBS; PBS with 0.3% Triton X-100; PBST; PFA; Parkinson’s disease; RCF; SDS–PAGE; TH; WT; analysis of variance; cell culture; ethylenediaminetetraacetic acid; fetal calf serum; horseradish peroxidase; knock-out; midbrain dopaminergic neurons; neurite growth; paraformaldehyde; phosphate-buffered saline; relative centrifugal force; sodium dodecyl sulfate polyacrylamide gel electrophoresis; tyrosine hydroxylase; wild-type.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Agents / toxicity
  • Age Factors
  • Animals
  • Antibodies / pharmacology
  • Cell Count
  • Cell Line, Transformed
  • Cell Line, Tumor
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Embryo, Mammalian
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Humans
  • Mesencephalon / cytology*
  • Mice
  • Mice, Knockout
  • Myelin Proteins / genetics
  • Myelin Proteins / immunology
  • Myelin Proteins / metabolism*
  • Neurites / physiology*
  • Neurons / cytology*
  • Neurons / physiology
  • Nogo Proteins
  • Organ Culture Techniques
  • Oxidopamine / toxicity

Substances

  • Adrenergic Agents
  • Antibodies
  • Myelin Proteins
  • Nogo Proteins
  • RTN4 protein, human
  • Rtn4 protein, mouse
  • Oxidopamine